JPMorgan Starts Bluebird Bio (BLUE) at Overweight
Tweet
Share
E-mailGet Alerts BLUE Hot Sheet
Price: $0.91 -1.09%
Rating Summary:
13 Buy, 16 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
13 Buy, 16 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
JPMorgan initiates coverage on Bluebird Bio (NASDAQ: BLUE) with a Overweight. PT $44.00.
For an analyst ratings summary and ratings history on Bluebird Bio click here. For more ratings news on Bluebird Bio click here.
Shares of Bluebird Bio closed at $30.65 yesterday.
For an analyst ratings summary and ratings history on Bluebird Bio click here. For more ratings news on Bluebird Bio click here.
Shares of Bluebird Bio closed at $30.65 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Agilon, NBH, Shoals, and Blue and Encourages Investors to Contact the Firm
- Monster Beverage (MNST) cut to sell at Truist as its 'no longer see it as a high growth story'
- Goldman Sachs Resumes JD.com, Inc (JD) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
